| Mobile Speech Plus | |
|
3037 Riverwood Way, Castle Rock, CO 80109-3807 | |
| (720) 556-6762 | |
| Not Available |
| Full Name | Mobile Speech Plus |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 3037 Riverwood Way, Castle Rock, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023534039 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Provider Name | Pamela Sue Berlin |
|---|---|
| Provider Type | Practitioner - Qualified Speech Language Pathologist |
| Provider Identifiers | NPI Number: 1043445299 PECOS PAC ID: 3577603430 Enrollment ID: I20171010002130 |
News Archive
Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.
A protein in the blood that is considered to be a key indicator of future heart disease may vary considerably among women and men, as well as blacks and whites, according to new research at UT Southwestern Medical Center.
Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse with another gene to drive an often-fatal form of leukemia in infants. By more accurately defining specific partner genes, researchers expect to better predict which infants may benefit from particular treatments.
Large or slow-healing wounds that do not receive adequate blood flow could benefit from a novel approach that combines a nanoscale graft onto which three different cell types are layered. Proper cell alignment on the nanograft allows for the formation of new blood vessel-like structures, as reported in of Tissue Engineering, Part A, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free for download on the Tissue Engineering website until May 26, 2016.
University of Toronto researchers on a quest to make opioid drugs less lethal have discovered a window of opportunity: a tiny channel in the brain where opioids interfere with the breathing mechanism.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mobile Speech Plus 3037 Riverwood Way, Castle Rock, CO 80109-3807 Ph: (720) 556-6762 | Mobile Speech Plus 3037 Riverwood Way, Castle Rock, CO 80109-3807 Ph: (720) 556-6762 |
News Archive
Researchers from the Fred Hutchinson Cancer Research Center in Seattle, WA have taken a closer look at existing mouse models of cancer, specifically comparing them to human cancer samples. These genetically engineered mouse models (which usually either overexpress a cancer-causing gene-or "oncogene"-or carry a deletion for a "tumor suppressor" gene) have been extensively used to understand human cancer biology in studies of drug resistance, early detection, metastasis, and cancer prevention, as well as for the preclinical development of novel targeted therapeutics.
A protein in the blood that is considered to be a key indicator of future heart disease may vary considerably among women and men, as well as blacks and whites, according to new research at UT Southwestern Medical Center.
Pediatric oncologists have identified specific genes, dubbed partner genes, that fuse with another gene to drive an often-fatal form of leukemia in infants. By more accurately defining specific partner genes, researchers expect to better predict which infants may benefit from particular treatments.
Large or slow-healing wounds that do not receive adequate blood flow could benefit from a novel approach that combines a nanoscale graft onto which three different cell types are layered. Proper cell alignment on the nanograft allows for the formation of new blood vessel-like structures, as reported in of Tissue Engineering, Part A, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free for download on the Tissue Engineering website until May 26, 2016.
University of Toronto researchers on a quest to make opioid drugs less lethal have discovered a window of opportunity: a tiny channel in the brain where opioids interfere with the breathing mechanism.
› Verified 8 days ago
Mrs. Melissa Walker, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2622 Mclean Ct, Castle Rock, CO 80109 Phone: 720-271-1974 | |
Speech Therapy Co Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2661 Castle Crest Dr, Castle Rock, CO 80104 Phone: 818-314-4273 | |
Noelle Karen Iorio, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 Wilcox St, Castle Rock, CO 80104 Phone: 303-387-0100 | |
Mrs. Jennifer Jackson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1105 Mcmurdo Cir, Castle Rock, CO 80108 Phone: 720-308-4543 | |
Nicole Belanger, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 Prairie Hawk Dr, Castle Rock, CO 80109 Phone: 303-387-0100 | |
Janet Tenbarge, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2661 Mashie Cir, Castle Rock, CO 80109 Phone: 303-246-6489 | |
Caitlin Croasdell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 Wilcox St, Castle Rock, CO 80104 Phone: 303-387-0100 |